Aiforia Technologies Oyj

HLSE:AIFORIA Stock Report

Market Cap: €101.2m

Aiforia Technologies Oyj Valuation

Is AIFORIA undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of AIFORIA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: AIFORIA (€3.56) is trading below our estimate of fair value (€4.51)

Significantly Below Fair Value: AIFORIA is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for AIFORIA?

Key metric: As AIFORIA is unprofitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for AIFORIA. This is calculated by dividing AIFORIA's market cap by their current revenue.
What is AIFORIA's PS Ratio?
PS Ratio36.6x
Sales€2.81m
Market Cap€101.20m

Price to Sales Ratio vs Peers

How does AIFORIA's PS Ratio compare to its peers?

The above table shows the PS ratio for AIFORIA vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average12.1x
HEALTH Nightingale Health Oyj
41.8x42.4%€189.5m
OPTOMED Optomed Oyj
6.2x29.8%€82.9m
OKDBV Oriola Oyj
0.1x4.8%€165.5m
PIHLIS Pihlajalinna Oyj
0.4x-6.7%€255.1m
AIFORIA Aiforia Technologies Oyj
36.6x50.9%€101.2m

Price-To-Sales vs Peers: AIFORIA is expensive based on its Price-To-Sales Ratio (36.6x) compared to the peer average (12.1x).


Price to Sales Ratio vs Industry

How does AIFORIA's PS Ratio compare vs other companies in the European Healthcare Services Industry?

5 CompaniesPrice / SalesEstimated GrowthMarket Cap
AIFORIA 36.6xIndustry Avg. 2.2xNo. of Companies11PS02.44.87.29.612+
5 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: AIFORIA is expensive based on its Price-To-Sales Ratio (36.6x) compared to the European Healthcare Services industry average (2.2x).


Price to Sales Ratio vs Fair Ratio

What is AIFORIA's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

AIFORIA PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio36.6x
Fair PS Ratio0.02x

Price-To-Sales vs Fair Ratio: AIFORIA is expensive based on its Price-To-Sales Ratio (36.6x) compared to the estimated Fair Price-To-Sales Ratio (0x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.


Discover undervalued companies